Tag: EuroPCR 2024
SoniVie announces advancements in its renal denervation programme
SoniVie, which has developed a novel Therapeutic Intra-Vascular Ultrasound System (TIVUS) to treat a...
Creating an ecosystem for innovation in medtech
At this year’s EuroPCR course (14–17 May, Paris, France), Shifamed president and chief executiv...
EuroPCR 2024: Coronary implant with “site-specific” antithrombotic delivery shows promise at one year
Twelve-month outcomes from the DESyne BDS Plus trial, evaluating a novel triple drug-eluting cor...
EuroPCR 2024: Leaflet splitting device may offer efficient option for avoiding coronary obstruction during valve-in-valve procedures
Insights from the investigational device exemption (IDE) pivotal study of the Shortcut (Pi-Cardia) l...
EuroPCR 2024: Coronary bioadaptor system shows sustained reduction of TLF at two years in BIOADAPTOR RCT
Two-year results from the BIOADAPTOR 1:1 randomised controlled trial (RCT), comparing the DynamX...
EuroPCR 2024: SMART trial data offer new insight on TAVI device choice in women
Data from the SMART trial—in which it was shown that a self-expanding transcatheter aortic valve...
EuroPCR 2024: TAVI device with intermediate sizing shown to be non-inferior to contemporary platforms in LANDMARK trial
Early outcomes following the use of a novel balloon-expandable transcatheter aortic valve implan...
EuroPCR 2024: NOTION-2 one-year results prompt questions over TAVI in young, low-risk patients with bicuspid aortic valves
Analysis of one-year results from the NOTION-2 trial, in which investigators compared transcathe...
Nicolas Dumonteil
Medicine and indeed interventional cardiology were not initially on the radar for Nicolas Dumont...
